Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 3:37 pm Unchanged | 13G | Coya Therapeutics Inc. COYA | VANGUARD GROUP INC | 845,424 5.550% | 0 (Unchanged) | View |
2024-11-04 1:27 pm Unchanged | 13G | Coya Therapeutics Inc. COYA | VANGUARD GROUP INC | 845,424 5.550% | 0 (Unchanged) | View |
2024-11-04 11:42 am Purchase | 13G | Coya Therapeutics Inc. COYA | VANGUARD GROUP INC | 845,424 5.550% | 845,424 (New Position) | View |
2024-02-14 4:46 pm Sale | 13G | Coya Therapeutics Inc. COYA | GREENLIGHT CAPITAL INC | 1,274,026 8.800% | -5,000 (-0.39%) | View |
2024-02-07 6:55 pm Purchase | 13G | Coya Therapeutics Inc. COYA | HIRSCHMAN ORIN | 1,164,372 8.100% | 471,977 (+68.17%) | View |
2023-12-12 4:05 pm Purchase | 13G | Coya Therapeutics Inc. COYA | GREENLIGHT CAPITAL INC | 1,279,026 8.900% | 1,279,026 (New Position) | View |
2023-02-14 4:36 pm Purchase | 13G | Coya Therapeutics Inc. COYA | Berman Howard | 954,338 9.900% | 15,000 (+1.60%) | View |
2023-02-14 4:06 pm Purchase | 13G | Coya Therapeutics Inc. COYA | Berman Howard | 939,338 14.200% | 939,338 (New Position) | View |
2023-01-05 08:30 am Purchase | 13G | Coya Therapeutics Inc. COYA | HIRSCHMAN ORIN | 692,395 7.200% | 692,395 (New Position) | View |